Company intelligence / Profile preview
Genus Lifesciences
Allentown, Pennsylvania, United Statesgenuslifesciences.com ↗
- Ownership
- Private
- Employees
- ~122
- Development stage
- Other
01
Overview
Genus Lifesciences develops, manufactures, and commercializes both branded and generic pharmaceutical products. The company specializes in bringing previously unapproved drugs through the FDA approval process using both NDA/ANDA pathways. It has a particular expertise in abuse-deterrent formulations via its DART technology. Its portfolio includes small molecule drugs targeting nervous system disorders, endocrine/metabolic diseases, neoplasms, among others. Products are distributed nationally across retail chains, hospitals, mail-order companies through wholesalers/distributors.
- Therapeutic areas
- NeurologyOncologyEndocrinology
- Modalities
- Small moleculeBranded formulationsGenerics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Global partnerships related to technology platforms
Beyond the preview
Go deeper on Genus Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genus Lifesciences.